vs
Side-by-side financial comparison of Allstate (ALL) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $922.0M, roughly 1.6× Allstate). Allstate runs the higher net margin — 266.6% vs -13.6%, a 280.2% gap on every dollar of revenue. On growth, Allstate posted the faster year-over-year revenue change (7.2% vs -5.3%). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ALL vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $1.5B |
| Net Profit | $2.5B | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | -1400.3% | -9.8% |
| Net Margin | 266.6% | -13.6% |
| Revenue YoY | 7.2% | -5.3% |
| Net Profit YoY | — | -288.1% |
| EPS (diluted) | $9.25 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $1.5B | ||
| Q3 25 | $17.3B | $1.6B | ||
| Q2 25 | $16.6B | $1.6B | ||
| Q1 25 | $16.5B | $1.5B | ||
| Q4 24 | $16.5B | $1.6B | ||
| Q3 24 | $16.6B | $1.6B | ||
| Q2 24 | $15.7B | $1.6B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $-205.0M | ||
| Q3 25 | $3.7B | $160.0M | ||
| Q2 25 | $2.1B | $145.0M | ||
| Q1 25 | $595.0M | $87.0M | ||
| Q4 24 | $1.9B | $109.0M | ||
| Q3 24 | $1.2B | $359.0M | ||
| Q2 24 | $331.0M | $195.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% |
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | -9.8% | ||
| Q3 25 | — | 15.2% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 14.6% |
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | -13.6% | ||
| Q3 25 | 21.7% | 10.0% | ||
| Q2 25 | 12.7% | 9.1% | ||
| Q1 25 | 3.6% | 5.8% | ||
| Q4 24 | 11.7% | 6.8% | ||
| Q3 24 | 7.2% | 22.7% | ||
| Q2 24 | 2.1% | 12.1% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $-0.78 | ||
| Q3 25 | $13.95 | $0.61 | ||
| Q2 25 | $7.76 | $0.56 | ||
| Q1 25 | $2.11 | $0.33 | ||
| Q4 24 | $7.07 | $0.42 | ||
| Q3 24 | $4.33 | $1.38 | ||
| Q2 24 | $1.13 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $31.6B | $752.0M |
| Total Assets | $124.0B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $574.0M | ||
| Q3 25 | $8.7B | $672.0M | ||
| Q2 25 | $9.6B | $599.0M | ||
| Q1 25 | $6.5B | $547.0M | ||
| Q4 24 | $4.5B | $675.0M | ||
| Q3 24 | $7.0B | $763.0M | ||
| Q2 24 | $5.3B | $704.0M |
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $8.6B | ||
| Q3 25 | $8.1B | $8.8B | ||
| Q2 25 | $8.1B | $8.9B | ||
| Q1 25 | $8.1B | $9.0B | ||
| Q4 24 | $8.1B | $8.9B | ||
| Q3 24 | $8.1B | $8.7B | ||
| Q2 24 | $8.1B | $8.7B |
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $752.0M | ||
| Q3 25 | $27.5B | $906.0M | ||
| Q2 25 | $24.0B | $733.0M | ||
| Q1 25 | $22.1B | $542.0M | ||
| Q4 24 | $21.4B | $472.0M | ||
| Q3 24 | $20.9B | $493.0M | ||
| Q2 24 | $18.6B | $144.0M |
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $12.9B | ||
| Q3 25 | $120.4B | $13.6B | ||
| Q2 25 | $115.9B | $13.5B | ||
| Q1 25 | $115.2B | $13.2B | ||
| Q4 24 | $111.6B | $13.1B | ||
| Q3 24 | $113.7B | $12.8B | ||
| Q2 24 | $108.4B | $12.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | 11.49× | ||
| Q3 25 | 0.29× | 9.74× | ||
| Q2 25 | 0.34× | 12.14× | ||
| Q1 25 | 0.37× | 16.52× | ||
| Q4 24 | 0.38× | 18.81× | ||
| Q3 24 | 0.39× | 17.75× | ||
| Q2 24 | 0.43× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $141.0M | ||
| Q3 25 | $3.3B | $264.0M | ||
| Q2 25 | $1.9B | $220.0M | ||
| Q1 25 | $2.0B | $75.0M | ||
| Q4 24 | $1.7B | $390.0M | ||
| Q3 24 | $3.2B | $141.0M | ||
| Q2 24 | $2.4B | $332.0M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $96.0M | ||
| Q3 25 | $3.2B | $218.0M | ||
| Q2 25 | $1.9B | $181.0M | ||
| Q1 25 | $1.9B | $43.0M | ||
| Q4 24 | $1.7B | $335.0M | ||
| Q3 24 | $3.1B | $99.0M | ||
| Q2 24 | $2.3B | $300.0M |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | 6.4% | ||
| Q3 25 | 18.8% | 13.6% | ||
| Q2 25 | 11.3% | 11.4% | ||
| Q1 25 | 11.4% | 2.8% | ||
| Q4 24 | 10.0% | 21.0% | ||
| Q3 24 | 18.9% | 6.3% | ||
| Q2 24 | 14.7% | 18.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 3.0% | ||
| Q3 25 | 0.3% | 2.9% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 0.3% | 3.5% | ||
| Q3 24 | 0.4% | 2.7% | ||
| Q2 24 | 0.4% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.88× | 1.65× | ||
| Q2 25 | 0.89× | 1.52× | ||
| Q1 25 | 3.30× | 0.86× | ||
| Q4 24 | 0.88× | 3.58× | ||
| Q3 24 | 2.69× | 0.39× | ||
| Q2 24 | 7.13× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
